November 2023
1. ZUO F, Wang Y, Xu X, Ding R, et al
   CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
   Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
   

   >> Share

   
   July 2023
2. WANG YD, Wu LL, Mai YN, Wang K, et al
   miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
   Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
   

   >> Share

   
   April 2023
3. LARSSON SC, Michaelsson K, Mola-Caminal M, Hoijer J, et al
   Corrigendum to "Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH" [Metab Volume 137, December 2022, 155329].
   Metabolism. 2023;143:155555.
   

   >> Share

   
   December 2022
4. HUANGFU G, Jaltotage B, Pang J, Lan NSR, et al
   Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemia.
   Metabolism. 2022;139:155370.
   

   >> Share

   
   October 2022
5. LARSSON SC, Michaelsson K, Mola-Caminal M, Hoijer J, et al
   Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH.
   Metabolism. 2022;137:155329.
   

   >> Share

   
   September 2022
6. TRICO D, Mengozzi A, Baldi S, Bizzotto R, et al
   Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals.
   Metabolism. 2022;134:155247.
   

   >> Share

   
   July 2022
7. BOUZONI E, Perakakis N, Connelly MA, Angelidi AM, et al
   PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.
   Metabolism. 2022 Jul 9:155265. doi: 10.1016/j.metabol.2022.155265.
   

   >> Share

   
   May 2021
8. HU X, Jia X, Xu C, Wei Y, et al
   Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells.
   Metabolism. 2021;120:154800.
   

   >> Share

   
   March 2021
9. XU X, Dong Y, Ma N, Kong W, et al
   MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
   Metabolism. 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.
   

   >> Share

   
   October 2020
10. SHIN SJ, Chen CH, Kuo WC, Chan HC, et al
    Disruption of retinoid homeostasis induces RBP4 overproduction in diabetes: O-GlcNAcylation involved.
    Metabolism. 2020;113:154403.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share